(Total Views: 36)
Posted On: 01/26/2017 10:14:49 AM
Post# of 18540
$MRPHF Cannabis Stocks Positioning to Regain Momentum in 2017
With the cannabis industry well-established as a serious player within the global economy, mergers and acquisitions are propelling the rapidly developing market to even higher heights. Cannabis operators in the markets this week include: Marapharm Ventures Inc. MRPHF, +1.37% MassRoots, Inc. MSRT, +0.26% OWC Pharmaceutical Research Corp. OWCP, -1.35% AXIM Biotechnologies, Inc. AXIM, -2.53% and 22nd Century Group, Inc. XXII, -2.46%
Marapharm Ventures Inc. (OTCQB:MRPHF) (CSE:MDM.CN) announced earlier this week plans to invests in Veritas Pharma Inc. Today Marapharm announces that is has entered into a subscription agreement to acquire 5 million 18 month $0.30 share purchase warrants of Veritas Pharma Inc. for consideration of $250,000.
"We like the Veritas Pharma business model and we know that we can play a big role in their growth. Marapharm has acquired shares and rights to acquire up to 15 million shares of Veritas, after taking into account 10 million share purchase warrants that we have. As a result of the investment, Marapharm will have the right to appoint members to the Veritas board of directors. There's great synergy with Veritas and Marapharm and the additional investment in the share purchase warrants will provide additional capital to Veritas as they execute on their business plan," says Linda Sampson, Marapharm CEO.
Marapharm has 300,000 square feet of medical marijuana licenses for its land and facilities in WA and NV and about two and a half years ago, Marapharm applied in Canada to Health Canada for a MMPR (Production and Sales) license and has passed the necessary security clearances.
http://www.marketwatch.com/story/cannabis-sto...2017-01-12
With the cannabis industry well-established as a serious player within the global economy, mergers and acquisitions are propelling the rapidly developing market to even higher heights. Cannabis operators in the markets this week include: Marapharm Ventures Inc. MRPHF, +1.37% MassRoots, Inc. MSRT, +0.26% OWC Pharmaceutical Research Corp. OWCP, -1.35% AXIM Biotechnologies, Inc. AXIM, -2.53% and 22nd Century Group, Inc. XXII, -2.46%
Marapharm Ventures Inc. (OTCQB:MRPHF) (CSE:MDM.CN) announced earlier this week plans to invests in Veritas Pharma Inc. Today Marapharm announces that is has entered into a subscription agreement to acquire 5 million 18 month $0.30 share purchase warrants of Veritas Pharma Inc. for consideration of $250,000.
"We like the Veritas Pharma business model and we know that we can play a big role in their growth. Marapharm has acquired shares and rights to acquire up to 15 million shares of Veritas, after taking into account 10 million share purchase warrants that we have. As a result of the investment, Marapharm will have the right to appoint members to the Veritas board of directors. There's great synergy with Veritas and Marapharm and the additional investment in the share purchase warrants will provide additional capital to Veritas as they execute on their business plan," says Linda Sampson, Marapharm CEO.
Marapharm has 300,000 square feet of medical marijuana licenses for its land and facilities in WA and NV and about two and a half years ago, Marapharm applied in Canada to Health Canada for a MMPR (Production and Sales) license and has passed the necessary security clearances.
http://www.marketwatch.com/story/cannabis-sto...2017-01-12
(0)
(0)
